Citadel Advisors
KALA icon

Citadel Advisors’s KALA BIO KALA Stock Holding History

Citadel Advisors’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.8K Buy
5,633
+4,505
+399% +$95.3K ﹤0.01% 12410
2025
Q4 		$31.3K Buy
+1,128
New +$50.5K ﹤0.01% 12215
2024
Q2 		– Sell
-269
Closed -$106K – 14888
2024
Q1 		$106K Buy
+269
New +$99.9K ﹤0.01% 11280
2022
Q4 		– Sell
-53
Closed -$30K – 15189
2022
Q3 		$30K Sell
53
-16
-23% -$12.6K ﹤0.01% 11908
2022
Q2 		$52K Buy
69
+38
+123% +$59.6K ﹤0.01% 11914
2022
Q1 		$108K Sell
31
-12
-28% -$31.4K ﹤0.01% 12212
2021
Q4 		$130K Sell
43
-1
-2% -$4.64K ﹤0.01% 12448
2021
Q3 		$289K Buy
44
+34
+340% +$293K ﹤0.01% 11126
2021
Q2 		$133K Buy
10
+1
+11% +$15.7K ﹤0.01% 12636
2021
Q1 		$145K Sell
9
-23
-72% -$449K ﹤0.01% 12088
2020
Q4 		$545K Buy
32
+21
+191% +$395K ﹤0.01% 7973
2020
Q3 		$212K Buy
+11
New +$253K ﹤0.01% 8714
2020
Q2 		– Sell
-99
Closed -$2.8M – 10173
2020
Q1 		$2.18M Buy
99
+46
+87% +$735K ﹤0.01% 4004
2019
Q4 		$489K Sell
53
-47
-47% -$454K ﹤0.01% 6832
2019
Q3 		$948K Buy
100
+42
+72% +$511K ﹤0.01% 5692
2019
Q2 		$921K Buy
58
+19
+49% +$315K ﹤0.01% 5821
2019
Q1 		$802K Sell
39
-25
-39% -$444K ﹤0.01% 5987
2018
Q4 		$786K Buy
+64
New +$1.11M ﹤0.01% 5683

Other funds holding KALA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Citadel Advisors's KALA Position: Q1 2026 in Review

Citadel Advisors increased its KALA BIO (KALA) stake by 399% in Q1 2026, buying an estimated $95.3K and bringing the position to 5,633 shares worth $48.8K. The position accounts for ﹤0.01% of the portfolio, ranked #12410.

Citadel Advisors first reported a position in KALA in Q4 2018 and has held it in 18 quarters since. The position peaked at $2.18M in Q1 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q1 2026.

  • Citadel Advisors held 5,633 shares of KALA BIO worth $48.8K as of Q1 2026.
  • Citadel Advisors bought 4,505 KALA BIO shares in Q1 2026, an estimated $95.3K.
  • KALA BIO made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12410 holding.
  • Citadel Advisors first reported a position in KALA BIO in Q4 2018 and has held it in 18 quarters since.
  • Citadel Advisors's KALA BIO position peaked at $2.18M in Q1 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.